Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bromocriptine in the Rett syndrome.

M Zappella1, A Genazzani, F Facchinetti

  • 1Department of Child Neurology and Psychiatry, Regional Hospital, Siena, Italy.

Brain & Development
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A model for decoding resistance in precision oncology: acquired resistance to FGFR inhibitors in cholangiocarcinoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Ranibizumab treatment improves the reading speed of patients with neovascular age-related macular degeneration: A nonrandomized clinical trial using the Radner reading chart.

Journal francais d'ophtalmologie·2024
Same author

Sexual functioning in women with functional hypothalamic amenorrhea: exploring the relevance of an underlying polycystic ovary syndrome (PCOS)-phenotype.

Journal of endocrinological investigation·2023
Same author

[Herpes Zoster Ophthalmicus after Pfizer BNT162b2 and Moderna mRNA-1273 vaccination in two young and immunocompetent patients].

Journal francais d'ophtalmologie·2022
Same author

The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

[Autism: a diagnostic dilemma].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2022

Bromocriptine treatment showed potential benefits for Rett syndrome patients, improving communication, motor skills, and reducing repetitive behaviors. Subsequent washout periods indicated the drug

Area of Science:

  • Neurology
  • Pediatrics
  • Pharmacology

Background:

  • Rett syndrome is a rare neurodevelopmental disorder affecting girls.
  • Current treatments for Rett syndrome are limited, focusing on symptom management.

Purpose of the Study:

  • To investigate the efficacy of bromocriptine in treating Rett syndrome.
  • To assess the drug's impact on various clinical symptoms and neuroendocrine markers.

Main Methods:

  • A cohort of 13 patients with Rett syndrome received bromocriptine for six months.
  • A two-month washout period followed, with subsequent re-initiation of bromocriptine.
  • Neuroendocrine assessments (prolactin, endorphins) were conducted before and after treatment.

Main Results:

Related Experiment Videos

  • Improvements were observed in communication, relaxation, sleep patterns, facial expressions, and vocalizations.
  • Reductions in hyperpnea, teeth grinding, and stereotypic hand movements were noted.
  • Washout led to a decline in benefits, with less pronounced effects upon re-treatment; endorphin responsiveness increased post-treatment.

Conclusions:

  • Bromocriptine demonstrates potential therapeutic benefits for Rett syndrome symptoms.
  • The drug's effects appear reversible, suggesting a direct pharmacological action.
  • Further research is warranted to explore bromocriptine's long-term efficacy and safety in Rett syndrome.